By directly targeting RASSF8 and inhibiting RASSF8 expression, upregulated miR-224 enhances proliferation, migration, and invasion of cervical cancer cells, and consequently promotes the progression of cervical cancer. Here, RASSF8 is linked to cervical cancer.